ENGENIOUS
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Oct 2024)
What this means for you
This application is over — abandoned 14 Oct 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90148530
- Mark type
- Stylized text
- Filed
- 31 Aug 2020
- Published for opposition
- 13 Jul 2021
- Abandoned
- 14 Oct 2024
- Attorney of record
- Caitlin Byczko
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for medical purposes, namely, vectors for delivering gene modification technologies into cells for the prevention and treatment of genetic diseases, infectious diseases, autoimmune diseases, diseases of oncology, hematology, immunodeficiency, and inborn errors of metabolism; chemical and diagnostic preparations in the nature of vectors for delivering gene modification technologies into cells for treatment of genetic diseases, infectious diseases, autoimmune diseases, diseases of oncology, hematology, immunodeficiency, and inborn errors of metabolism
Owner
- Ensoma, Inc., Boston, MA, US
- Ensoma, Inc., Boston, MA, US
Prosecution history
- 14 Oct 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Oct 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 26 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jan 2024 — SOU EXTENSION 5 GRANTED
- 09 Jan 2024 — SOU EXTENSION 5 FILED
- 25 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2023 — SOU EXTENSION 4 GRANTED
- 07 Jul 2023 — SOU EXTENSION 4 FILED
- 07 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 10 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Feb 2023 — SOU EXTENSION 3 GRANTED
- 08 Feb 2023 — SOU EXTENSION 3 FILED
- 08 Feb 2023 — SOU TEAS EXTENSION RECEIVED